Liang, XC., Cui, LY., Guo, SS. et al. Clinical study of Jinmaitong composita ()on diabetic peripheral neuropathy)on diabetic peripheral neuropathy., CJIM 7, 103–106 (2001). https://doi.org/10.1007/BF02935013
Xiao-Chun Liang, Li-Ying Cui, Sai-Shan Guo, et al. Clinical study of Jinmaitong composita ( )on diabetic peripheral neuropathy)on diabetic peripheral neuropathy. [J]. Chinese Journal of Integrative Medicine 7(2):103-106(2001)
Liang, XC., Cui, LY., Guo, SS. et al. Clinical study of Jinmaitong composita ()on diabetic peripheral neuropathy)on diabetic peripheral neuropathy., CJIM 7, 103–106 (2001). https://doi.org/10.1007/BF02935013DOI:
Xiao-Chun Liang, Li-Ying Cui, Sai-Shan Guo, et al. Clinical study of Jinmaitong composita ( )on diabetic peripheral neuropathy)on diabetic peripheral neuropathy. [J]. Chinese Journal of Integrative Medicine 7(2):103-106(2001) DOI: 10.1007/BF02935013.
Clinical study of Jinmaitong composita ( )on diabetic peripheral neuropathy)on diabetic peripheral neuropathy
摘要
Objective: To verify the effect of Jinmaitong composita (JMTC) on red blood cell aldose reductase activity (RBC-AR)
red blood cell sorbitol (RBC-S) and nerve conductive velocity in diabetic peripheral neuropathy (DN) patients. Methods: Sixty-six patients with DN were randomly divided into two groups
33 patients in the treated group treated with JMTC and 33 patients in the control group treated with Jingui Shenqi capsule (JGSQ). RBC-AR
RBC-S and nerve transmission speed were observed before and after three months treatment.Results: Level of RBC-AR
RBC-S apparently decreased and nerve conductive velocity increased (P <0.05
P<0.01) after JMTC treatment.Conclusion: JMTC can improve the nerve conductive velocity significantly with a lowering of RBC-AR and RBC-S and has a good result in treating diabetic peripheral neuropathy.
Abstract
Objective: To verify the effect of Jinmaitong composita (JMTC) on red blood cell aldose reductase activity (RBC-AR)
red blood cell sorbitol (RBC-S) and nerve conductive velocity in diabetic peripheral neuropathy (DN) patients. Methods: Sixty-six patients with DN were randomly divided into two groups
33 patients in the treated group treated with JMTC and 33 patients in the control group treated with Jingui Shenqi capsule (JGSQ). RBC-AR
RBC-S and nerve transmission speed were observed before and after three months treatment.Results: Level of RBC-AR
RBC-S apparently decreased and nerve conductive velocity increased (P <0.05
P<0.01) after JMTC treatment.Conclusion: JMTC can improve the nerve conductive velocity significantly with a lowering of RBC-AR and RBC-S and has a good result in treating diabetic peripheral neuropathy.
Song Hp, Li J, Han Xy, et al. Red blood cell aldose reductase activity and cell damage of NIDDM patients. Chin J Endocrinol Metab 1992;8(2): 72–74.
Zhou Yp, Zhang Jq. Measurement of aldose reductase by fluorescence intensity and its utilization on measuring lens AR of diabetic rats. Chin J Endocrinol Metab 1989;5(3):159–161.
Greene Da, Lattimer Sa. Altered sorbitol and myo-inositol metabolism as the basis for defective protein kinase C and Na+-K+-ATPase regulation in diabetic neuropathy. Ann NY Acad Sci 1986; 488:344–340.
Hotta N, Kakuta H, Fukasawa M, et al. Effects of a fructose-rich diet and the aldose reductase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocintreated rats. Diabetologia 1985; 28:176–180.
Effects of Jinmaitong Capsule (筋脉通胶囊) on ciliary neurotrophic factor in sciatic nerves of diabetes mellitus rats
Experiences in treating diabetic peripheral neuropathy with traditional Chinese medicine
Role of traditional chinese and western medicines that inhibit aldose reductase in the treatment of diabetic neuropathy
Silybin decreases erythrocytic sorbitol level and improves peripheral nerve conduction velocity in patients with non-insulin dependent diabetes mellitus
Combination of quercetin, cinnamaldehyde and hirudin protects rat dorsal root ganglion neurons against high glucose-induced injury through Nrf-2/HO-1 activation and NF-κB inhibition
Related Author
No data
Related Institution
Department of Traditional Chinese Medicine, Translational Medicine Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Xiyuan Hospital, China Academy of Chinese Medical Sciences
Beijing Union Hospital, PUMC, Academy of Chinese Medical Sciences
Department of Endocrinology, Changhai Hospital, Second Military Medical University
Department of Pathology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College